Edition:
United States

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

144.90CHF
17 Aug 2018
Change (% chg)

CHF1.20 (+0.84%)
Prev Close
CHF143.70
Open
CHF143.80
Day's High
CHF146.30
Day's Low
CHF142.50
Volume
3,978
Avg. Vol
15,596
52-wk High
CHF182.50
52-wk Low
CHF125.20

Latest Key Developments (Source: Significant Developments)

Ypsomed sees temporary profit decline in 2019/20, then rebound
Wednesday, 7 Mar 2018 08:53am EST 

March 7 (Reuters) - Ypsomed Holding AG ::YPSOMED SAYS FOR THE NEXT FINANCIAL YEAR 2018/19, YPSOMED CONTINUES TO EXPECT AN INCREASED OPERATING PROFIT.YPSOMED SAYS AS ANNOUNCED IN NOVEMBER, YPSOMED EXPECTS A TEMPORARY DECLINE IN PROFITS IN THE FOLLOWING FINANCIAL YEAR 2019/20, FOLLOWED BY A CLEAR AND LONG-TERM INCREASE IN PROFITABILITY.YPSOMED SAYS WILL PUBLISH MORE DETAILED INFORMATION AND A RANGE OF OUTLOOK FIGURES WITH THE PUBLICATION OF THE FINANCIAL YEAR 2017/18 FIGURES AT THE END OF MAY.  Full Article

Ypsomed increases its forecast to an operating result of CHF 60 mln
Thursday, 9 Nov 2017 02:42am EST 

Nov 9(Reuters) - YPSOMED HOLDING AG ::SAYS FIRST SIX MONTHS OF 2017/18, A CONSOLIDATED TOTAL TURNOVER OF CHF 213.4 MILLION. THE GROWTH CORRESPONDS TO AN INCREASE IN TURNOVER OF 15.1 PCT (PREVIOUS YEAR: CHF 185.4 MILLION).SAYS THE NET PROFIT FOR THE REPORTING PERIOD AMOUNTS TO CHF 23.4 MILLION (PREVIOUS YEAR CHF 22.4 MILLION).SAYS OPERATING RESULT AMOUNTS TO CHF 26.9 MILLION WITH AN EBIT MARGIN OF 12.9  PCT.SAYS EXPECTS A GROWTH IN TURNOVER OF APPROXIMATELY 18 PCT VERSUS THE PRESENTLY FORECAST 15 PCT AND INCREASES THE FORECAST TO AN OPERATING RESULT OF AROUND CHF 60 MILLION FOR THE BUSINESS YEAR 2017/18.  Full Article

Ypsomed and US Bigfoot Biomedical company announce partnership
Tuesday, 24 Oct 2017 01:07am EDT 

Oct 24 (Reuters) - YPSOMED HOLDING AG ::‍YPSOMED AND US BIGFOOT BIOMEDICAL COMPANY TODAY ANNOUNCED THEIR AGREEMENT FOR A PARTNERSHIP​.‍YPSOMED WILL SUPPLY BIGFOOT BIOMEDICAL WITH A MODIFIED, PATENTED VERSION OF ORBIT INFUSION SET​.  Full Article

Ypsomed to separate from Insulet
Friday, 21 Jul 2017 01:12am EDT 

July 21 (Reuters) - YPSOMED HOLDING AG ::TO SEPARATE FROM INSULET AND EXTEND ITS PORTFOLIO WITH AN OWN PATCH PUMP IN MID-TERM.AFTER 30 JUNE 2018, INSULET CORP. WILL TAKE OVER OMNIPOD BUSINESS WORLDWIDE.DETAILS OF TRANSFER PROCESS ARE PRESENTLY BEING WORKED OUT BETWEEN TWO PARTIES.‍DISTRIBUTION AGREEMENT WITH INSULET CORP. WILL END AS PER 30 JUNE 2018​.‍PARTIES COULD NOT AGREE ON EXTENDING CONTRACT AS PRICE DEMANDED BY INSULET CORP. WOULD HAVE MADE CONTINUED ECONOMIC VIABILITY IMPOSSIBLE​.IN FUTURE, YPSOMED WILL FOCUS ON ITS OWN DEVELOPMENTS.IS TO RECEIVE SOME USD 50 MILLION IN COMPENSATION FROM INSULET CORP. TO SET UP EUROPEAN DISTRIBUTION STRUCTURES FOR MYLIFE OMNIPOD.  Full Article

Ypsomed Holding FY net profit up 29 pct at CHF 35.8 million
Wednesday, 24 May 2017 01:15am EDT 

May 24 (Reuters) - YPSOMED HOLDING AG ::FY SALES OF CHF 389.6 MILLION (PREVIOUS YEAR: CHF 336.9 MILLION).FY EBIT ALSO INCREASED BY 24.4% COMPARED TO PREVIOUS YEAR, FROM CHF 44.4 MILLION TO CHF 55.3 MILLION.FY NET PROFITS WERE RAISED BY 29.1% FROM CHF 35.8 MILLION TO CHF 46.2 MILLION.SOME DEMANDING TASKS LIE AHEAD FOR COMING FINANCIAL YEAR, BUT YPSOMED REMAINS CONFIDENT AND AGAIN EXPECTS A GROWTH IN SALES OF APPROXIMATELY 15% FOR FINANCIAL YEAR 2017/18.  Full Article

BRIEF-Ypsomed FY Net Profit Increases To CHF 52.1 Million

* FY CONSOLIDATED SALES OF CHF 466.1 MILLION (PRIOR YEAR: CHF 389.6 MILLION)